SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 47 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $365,000 | -40.1% | 20,981 | -24.6% | 0.00% | – |
| Q4 2021 | $609,000 | +19.4% | 27,826 | +4.2% | 0.00% | – |
| Q3 2021 | $510,000 | -5.0% | 26,700 | -14.7% | 0.00% | – |
| Q2 2021 | $537,000 | -24.2% | 31,289 | -1.2% | 0.00% | – |
| Q1 2021 | $708,000 | +51.9% | 31,669 | +51.2% | 0.00% | – |
| Q4 2020 | $466,000 | +79.9% | 20,946 | +19.2% | 0.00% | – |
| Q3 2020 | $259,000 | -19.3% | 17,566 | -19.0% | 0.00% | – |
| Q2 2020 | $321,000 | +66.3% | 21,686 | +23.1% | 0.00% | – |
| Q1 2020 | $193,000 | +11.6% | 17,621 | -10.7% | 0.00% | – |
| Q4 2019 | $173,000 | +16.9% | 19,727 | -0.5% | 0.00% | – |
| Q3 2019 | $148,000 | -13.5% | 19,826 | +8.3% | 0.00% | – |
| Q2 2019 | $171,000 | +147.8% | 18,314 | +39.2% | 0.00% | – |
| Q1 2019 | $69,000 | -82.8% | 13,152 | -61.7% | 0.00% | – |
| Q3 2017 | $401,000 | -21.5% | 34,310 | -6.2% | 0.00% | -100.0% |
| Q2 2017 | $511,000 | +64.3% | 36,565 | +61.4% | 0.00% | – |
| Q1 2017 | $311,000 | +87.3% | 22,654 | -2.0% | 0.00% | – |
| Q4 2016 | $166,000 | -53.6% | 23,127 | -2.0% | 0.00% | -100.0% |
| Q3 2016 | $358,000 | +56.3% | 23,591 | +1.3% | 0.00% | – |
| Q2 2016 | $229,000 | – | 23,293 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |